<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">02482</article-id><article-id pub-id-type="doi">10.7554/eLife.02482</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genes and Chromosomes</subject></subj-group></article-categories><title-group><article-title>SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-11251"><name><surname>Carvalho</surname><given-names>Sílvia</given-names></name><aff><addr-line><named-content content-type="department">SAlmeida Unit</named-content></addr-line>, <institution>Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11252"><name><surname>Vítor</surname><given-names>Alexandra C</given-names></name><aff><addr-line><named-content content-type="department">SAlmeida Unit</named-content></addr-line>, <institution>Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11253"><name><surname>Sridhara</surname><given-names>Sreerama C</given-names></name><aff><addr-line><named-content content-type="department">SAlmeida Unit</named-content></addr-line>, <institution>Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11254"><name><surname>Martins</surname><given-names>Filipa B</given-names></name><aff><addr-line><named-content content-type="department">SAlmeida Unit</named-content></addr-line>, <institution>Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11255"><name><surname>Raposo</surname><given-names>Ana C</given-names></name><aff><addr-line><named-content content-type="department">SAlmeida Unit</named-content></addr-line>, <institution>Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11256"><name><surname>Desterro</surname><given-names>Joana MP</given-names></name><aff><addr-line><named-content content-type="department">Instituto de Medicina Molecular</named-content></addr-line>, <institution>Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11257"><name><surname>Ferreira</surname><given-names>João</given-names></name><aff><addr-line><named-content content-type="department">Instituto de Medicina Molecular</named-content></addr-line>, <institution>Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-11171"><name><surname>de Almeida</surname><given-names>Sérgio F</given-names></name><aff><addr-line><named-content content-type="department">SAlmeida Unit</named-content></addr-line>, <institution>Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country><email>sergioalmeida@fm.ul.pt</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1082"><name><surname>Espinosa</surname><given-names>Joaquin M</given-names></name><role>Reviewing editor</role><aff><institution>University of Colorado</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>06</day><month>05</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e02482</elocation-id><supplementary-material><ext-link xlink:href="elife-02482-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>06</day><month>02</month><year>2014</year></date><date date-type="accepted"><day>30</day><month>04</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014, Carvalho et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Carvalho et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Histone modifications establish the chromatin states that coordinate the DNA damage response. Here, we show that SETD2, the enzyme that trimethylates histone H3 lysine 36 (H3K36me3), is required for ATM activation upon DNA double-strand breaks (DSBs). Moreover, we find that SETD2 is necessary for homologous recombination repair of DSBs by promoting the formation of RAD51 presynaptic filaments. In agreement, SETD2-mutant clear cell renal cell carcinoma (ccRCC) cells displayed impaired DNA damage signaling. However, despite the persistence of DNA lesions, SETD2-deficient cells failed to activate p53, a master guardian of the genome rarely mutated in ccRCC and showed decreased cell survival after DNA damage. We propose that this novel SETD2-dependent role provides a chromatin bookmarking instrument that facilitates signaling and repair of DSBs. In ccRCC, loss of SETD2 may afford an alternative mechanism for the inactivation of the p53-mediated checkpoint without the need for additional genetic mutations in TP53.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>